Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Necmi Eren

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Nephrology|June 23, 2023
Thirst intensity survey in ADPKD patientsSibel Gokcay Gocay Bek, Nuriye Yıldız, Mahmud Islam, et al.
Kidney International|March 29, 2024
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathyRichard Lafayette, Sean Barbour, Rubeen Israni, et al.
Emerging Infectious Diseases|October 22, 2004
Crimean-Congo hemorrhagic fever in TurkeyS Sami Karti, Zekaver Odabasi, Volkan Korten, et al.
The New England Journal of Medicine|November 6, 2025
A Phase 3 Trial of Atacicept in Patients with IgA NephropathyRichard Lafayette, Sean J Barbour, Robert M Brenner, et al.
Clinical and Experimental Nephrology|October 11, 2020
Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working GroupZeki Aydin, Kultigin Turkmen, Fatih Dede, et al.
Clinical Kidney Journal|October 18, 2024
Prognostic factors and validation of the histologic chronicity score for C3 glomerulopathy: a registry analysisSafak Mirioglu, Egemen Cebeci, Halil Yazici, et al.
BMC Nephrology|January 15, 2021
Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19Kenan Turgutalp, Savas Ozturk, Mustafa Arici, et al.
Nephrology (Carlton, Vic.)|March 19, 2026
The Optimal Management Strategy for IGA Nephropathy Patients With Different Clinical PresentationsSavas Ozturk, Abdullah Sumnu, Necmi Eren, et al.
The New England Journal of Medicine|March 30, 2026
Iptacopan in IgA Nephropathy - Final 24-Month DataJonathan Barratt, Necmi Eren, Naoki Kashihara, et al.
BMC Nephrology|October 1, 2024
Observational study of immunosuppressive treatment patterns and outcomes in primary membranous nephropathy: a multicenter retrospective analysisAyşe Serra Artan, Şafak Mirioğlu, Rabia Hacer Hocaoğlu, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Nephrology|June 23, 2023
Thirst intensity survey in ADPKD patientsSibel Gokcay Gocay Bek, Nuriye Yıldız, Mahmud Islam, et al.
Kidney International|March 29, 2024
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathyRichard Lafayette, Sean Barbour, Rubeen Israni, et al.
Emerging Infectious Diseases|October 22, 2004
Crimean-Congo hemorrhagic fever in TurkeyS Sami Karti, Zekaver Odabasi, Volkan Korten, et al.
The New England Journal of Medicine|November 6, 2025
A Phase 3 Trial of Atacicept in Patients with IgA NephropathyRichard Lafayette, Sean J Barbour, Robert M Brenner, et al.
Clinical and Experimental Nephrology|October 11, 2020
Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working GroupZeki Aydin, Kultigin Turkmen, Fatih Dede, et al.
Clinical Kidney Journal|October 18, 2024
Prognostic factors and validation of the histologic chronicity score for C3 glomerulopathy: a registry analysisSafak Mirioglu, Egemen Cebeci, Halil Yazici, et al.
BMC Nephrology|January 15, 2021
Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19Kenan Turgutalp, Savas Ozturk, Mustafa Arici, et al.
Nephrology (Carlton, Vic.)|March 19, 2026
The Optimal Management Strategy for IGA Nephropathy Patients With Different Clinical PresentationsSavas Ozturk, Abdullah Sumnu, Necmi Eren, et al.
The New England Journal of Medicine|March 30, 2026
Iptacopan in IgA Nephropathy - Final 24-Month DataJonathan Barratt, Necmi Eren, Naoki Kashihara, et al.
BMC Nephrology|October 1, 2024
Observational study of immunosuppressive treatment patterns and outcomes in primary membranous nephropathy: a multicenter retrospective analysisAyşe Serra Artan, Şafak Mirioğlu, Rabia Hacer Hocaoğlu, et al.
Pageof 7